SARS-CoV-2 Omicron breakthrough infection less immunogenic than Delta
Scientists around the world have set a precedent for developing a vaccine against the ongoing coronavirus disease 2019 (COVID-19) pandemic, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). I have been working at a speed that is not. To date, all available COVID-19 vaccines have been developed against the ancestral SARS-CoV-2 strain spiked (S) protein first … Read more